Related Experiment Video
Updated: Feb 22, 2026

Antibiotic Dereplication Using the Antibiotic Resistance Platform
Published on: October 17, 2019
ACS @150: Role of Medicinal Chemistry in Antibacterial Drug Discovery
Yash Acharya1, Jayanta Haldar1,2
1Antimicrobial Research Laboratory, New Chemistry Unit, Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Jakkur, Bengaluru-560064, India.
Abstract:
Medicinal chemistry has evolved over the years, to meet challenges in the field of therapeutic development. Since the dawn of the antibiotic era, this field has stepped up and contributed extensively to antibacterial drug development, right from developing better and more potent analogues, to improving pharmacokinetics and stability, from overcoming resistance, to facilitating better delivery through formulations. The contributions of medicinal chemistry, across these and many other areas, have shaped medicine, and facilitated its transition from an empirical discipline to a rigorous science, with significant progress being made in the last five decades. Commemorating the 150 years of the American Chemical Society, this Viewpoint highlights the central role of medicinal chemistry in shaping antibacterial drug discovery over the decades, and explores the emerging paradigms which are bound to influence this field.
More Related Videos
Related Concept Videos
Drug Discovery: Overview
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Microorganisms in Medicine and Therapeutics
Antibiotic Selection
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

